Vice President, Clinical Research at Gilead Sciences

Infectious Disease

Dr. Diana M. Brainard, MD

Diana M. Brainard, MD works in the field of Infectious Disease. She researched medicine at Tulane University School of Medicine. Dr. Diana M. Brainard is a published doctor as well. She has 15 publications published. The latest was: GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.

Publications

Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.
Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection.
A pharmacokinetic comparison of adult and pediatric formulations of raltegravir in healthy adults.
Lack of a clinically meaningful pharmacokinetic effect of rifabutin on raltegravir: in vitro/in vivo correlation.
Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics.
Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals.
Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor.
Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.
Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.
Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120.
Images in clinical medicine. Thoracic echinococcosis.
Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo.
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.

Schools

Tulane University of Louisiana
Mass Gen Hospital

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

Massachusetts General Hospital
Tulane University School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Mark J. Siedner, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Paula I. Watnick, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Emily A. Kendall, MD
	Dr. Irmgard Behlau, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Elana S. Rosenthal, MD This Doctor is OpenDoctor Recommended.
	Dr. Lenette L. Lu, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael A. Lobritz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Douglas S. Kwon, MD This Doctor is OpenDoctor Recommended.
	Dr. Mary L. Pisculli, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer Johnson, MD This Doctor is OpenDoctor Recommended.
	Dr. Kimon C. Zachary, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Joshua T. Thaden, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul A. Trowbridge, MD This Doctor is OpenDoctor Recommended.
	Dr. Robin R. Ingalls, MD This Doctor is OpenDoctor Recommended. This doctor has more publications